Cargando…

Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma

Papillary renal carcinoma (PRCC) is one of the important subtypes of kidney cancer, with a high degree of heterogeneity. At present, there is still a lack of robust and accurate biomarkers for the diagnosis, prognosis and treatment selection of PRCC. Considering the important role of tumor immunity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xianghong, Qiu, Shi, Jin, Di, Jin, Kun, Zheng, Xiaonan, Yang, Lu, Wei, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680997/ https://www.ncbi.nlm.nih.gov/pubmed/33240321 http://dx.doi.org/10.3389/fgene.2020.569884

Ejemplares similares

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes
por: Qiu, Huaide, et al.
Publicado: (2020)

Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database
por: Jin, Kun, et al.
Publicado: (2021)

ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer
por: Jin, Yuchen, et al.
Publicado: (2022)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022)

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
por: Cui, Mengjing, et al.
Publicado: (2022)

A Prognostic Autophagy-Related Gene Pair Signature and Small-Molecule Drugs for Hepatocellular Carcinoma
por: Song, ZeBing, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma
por: Chen, Dongshan, et al.
Publicado: (2022)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
por: Liu, Nian, et al.
Publicado: (2020)

Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Tang, Qiang, et al.
Publicado: (2022)

Exploring Immune-Related Prognostic Signatures in the Tumor Microenvironment of Colon Cancer
por: Cao, Lichao, et al.
Publicado: (2022)

Comprehensive analysis reveals a 5-gene signature and immune cell infiltration in Alzheimer’s disease with qPCR validation
por: Jin, Fanmao, et al.
Publicado: (2022)

A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma
por: Wu, Zhipeng, et al.
Publicado: (2020)

A Novel Pyroptosis-Related Gene Signature for Predicting Prognosis in Kidney Renal Papillary Cell Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Individualized prognostic signature for pancreatic carcinoma validated by integrating immune-related gene pairs (IRGPs)
por: Li, Yecheng, et al.
Publicado: (2021)

A novel necroptosis-related gene signature associated with immune landscape for predicting the prognosis of papillary thyroid cancer
por: Wang, Zhiyuan, et al.
Publicado: (2022)

A Novel Ferroptosis-Related LncRNA Pair Prognostic Signature Predicts Immune Landscapes and Treatment Responses for Gastric Cancer Patients
por: Li, Jiazheng, et al.
Publicado: (2022)

N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma
por: Maimaiti, Aierpati, et al.
Publicado: (2022)

One Ferroptosis-Related Gene-Pair Signature Serves as an Original Prognostic Biomarker in Lung Adenocarcinoma
por: Li, Lei, et al.
Publicado: (2022)

Corrigendum: A novel ferroptosis-related LncRNA pair prognostic signature predicts immune landscapes and treatment responses for gastric cancer patients
por: Li, Jiazheng, et al.
Publicado: (2022)

Development of an Immune-Related Prognostic Signature in Breast Cancer
por: Xie, Peiling, et al.
Publicado: (2020)

An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer
por: Liu, Qing, et al.
Publicado: (2022)

Development and Validation of a Three-Gene Prognostic Signature Based on Tumor Microenvironment for Gastric Cancer
por: Wang, Qian, et al.
Publicado: (2022)

A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

A Prognostic Signature for Clear Cell Renal Cell Carcinoma Based on Ferroptosis-Related lncRNAs and Immune Checkpoints
por: Dong, Yunze, et al.
Publicado: (2022)

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022)

Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer
por: Pei, Jianying, et al.
Publicado: (2020)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma
por: Yang, Wenlong, et al.
Publicado: (2022)

Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma
por: Chai, Xiu-kun, et al.
Publicado: (2021)

Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
por: Wang, Jixin, et al.
Publicado: (2021)

Comprehensive Analyses of Mutation-Derived Long-Chain Noncoding RNA Signatures of Genome Instability in Kidney Renal Papillary Cell Carcinoma
por: Li, Jian, et al.
Publicado: (2022)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Prognostic risk of immune-associated signature in the microenvironment of brain gliomas
por: Tao, Yaling, et al.
Publicado: (2023)

Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
por: Zhang, Lu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8jq7ne495s9gtpscfnjp2sa4v8